Entries of Haferlach, T. on the publication server

Krug, U., Berdel, W. E., Gale, R. P., Haferlach, C., Schnittger, S., Müller-Tidow, C., Braess, J., Spiekermann, K., Staib, P., Beelen, D., Serve, H. , Schliemann, C., Stelljes, M., Balleisen, L., Maschmeyer, G., Grüneisen, A., Eimermacher, H., Giagounidis, A., Rasche, H., Hehlmann, R., Lengfelder, E., Thiel, E., Reichle, A., Aul, C., Ludwig, W.-D., Kern, W., Haferlach, T., Köpcke, W., Görlich, D., Sauerland, M. C., Heinecke, A., Wörmann, B. J., Hiddemann, W. and Büchner, T. (2016) Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemia. Leukemia 30 (6), pp. 1230-1236. Fulltext not available.

Thomas, S. , Schelker, R., Klobuch, S., Zaiss, S., Troppmann, M., Rehli, M. , Haferlach, T., Herr, W. and Reichle, A. (2015) Biomodulatory therapy induces complete molecular remission in chemorefractory acute myeloid leukemia. Haematologica 100 (1), e4-e6. Fulltext not available.

Schnittger, S., Bacher, U., Haferlach, C., Beelen, D., Bojko, P., Burkle, D., Dengler, R., Distelrath, A., Eckart, M., Eckert, R., Fries, S., Knoblich, J., Kochling, G., Laubenstein, H.-P., Petrides, P., Planker, M., Pihusch, R., Weide, R., Kern, W. and Haferlach, T. (2009) Characterization of 35 new cases with four different MPLW515 mutations and essential thrombocytosis or primary myelofibrosis. Haematologica 94 (1), pp. 141-144. Fulltext not available.

Lengfelder, E., Haferlach, C., Saussele, S., Haferlach, T., Schultheis, B., Schnittger, S., Ludwig, W.-D., Staib, P., Aul, C., Grüneisen, A., Kern, W., Reichle, A., Serve, H. , Berdel, W. E., Braess, J., Spiekermann, K., Wörmann, B., Sauerland, M.-C., Heinecke, A., Hiddemann, W., Hehlmann, R. and Büchner, T. (2009) High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG. Leukemia 23 (12), pp. 2248-2258. Fulltext not available.

Kuchenbauer, F., Schoch, C., Holler, E., Haferlach, T., Hiddemann, W. and Schnittger, S. (2005) A rare case of acute myeloid leukemia with a CHIC2-ETV6 fusiongen and multiple other molecular aberrations. Leukemia 19 (12), pp. 2366-2368. Fulltext not available.